S.-F. Wu et al. / Tetrahedron 66 (2010) 1653–1660
1657
added. After the reaction was judged to be completed by TLC
monitoring, saturated aqueous solutions of Na2S2O3 (4 mL) and
NaHCO3 (15 mL) were added successively. The yellow mixture was
extracted with EtOAc (3ꢂ30 mL), and the combined organic layers
were washed with brine, dried over anhydrous Na2SO4, filtered, and
concentrated under reduced pressure. The residue was purified by
flash column chromatography on silica gel (eluent:EtOAc–PE) to
give the coupling product 9.
J¼11.5 Hz, PhCH2), 3.98 (d, 1H, J¼5.4 Hz, H-4), 3.70 (d, 1H, J¼4.6 Hz,
H-3), 3.46 (d, 1H, J¼11.4 Hz, H-5), 3.29 (dd, 1H, J¼4.6, 7.3 Hz, H-2),
3.23 (dd, 1H, J¼5.4, 11.4 Hz, H-5); 13C NMR (100 MHz, CDCl3)
d
140.0, 137.4, 137.2, 133.6, 128.6 (2C), 128.5 (2C), 128.4 (2C), 128.3
(2C) 128.0, 127.9 (2C), 127.8, 127.7 (2C), 83.7, 80.3, 78.7, 74.5, 71.6,
71.5, 61.5; MS (ESI, m/z): 462 (MþNaþ, 100), 440 (MþHþ, 51). Anal.
Calcd for C25H26ClNO4: C, 64.77; H, 6.04; N, 4.20. Found: C, 64.91; H,
6.42; N, 4.45.
4.3.1. (2R,3S,4S)-3,4-Bis(benzyloxy)-2-(hydroxydiphenylmethyl)-N-
4.3.4. (2S,3S,4S)-3,4-Bis(benzyloxy)-2-[hydroxy(4-methox-
hydroxypyrrolidine (9a). Following the general procedure, the
yphenyl)methyl]-N-hydroxypyrrolidine (9d). Following the general
SmI2-mediated
a-hydroxyalkylations of 8 (134 mg, 0.451 mmol)
procedure, the SmI2-mediated a-hydroxyalkylations of 8 (160 mg,
with benzophenone (246 mg, 1.35 mmol) gave compound 9a as
0.54 mmol) with 4-methoxybenzaldehyde (0.2 mL, 1.61 mmol)
gave compound 9d as a mixture of two diastereomers in 72:28 ratio
(determined by 1H NMR, dH 3.27, 3.14) (eluent:EtOAc–PE¼1:3;
98 mg, combined yield: 42%). A part of the major diastereomer was
a single diastereomer (eluent:EtOAc–PE¼1:10; 196 mg) in 90%
20
yield. 9a: colorless wax. Rf 0.60 (EtOAc–PE¼1:4); [
a]
ꢀ30.3 (c
D
0.98, CHCl3); IR (film): 3437, 2922, 2853, 1585, 1402, 1122,
1084 cmꢀ1 1H NMR (400 MHz, CDCl3)
;
d
7.74–7.68 (m, 2H, Ph-H),
isolated in pure form from column chromatographic separation.
20
7.67–7.61 (m, 2H, Ph-H), 7.36–7.13 (m, 16H, Ph-H), 4.53 (d, 1H,
J¼11.8 Hz, PhCH2), 4.38 (d, 1H, J¼11.8 Hz, PhCH2), 4.25 (br
d, 1H, J¼2.7 Hz, H-2), 4.16 (br s, 1H, OH, D2O exchangeable), 4.11
(d, 1H, J¼11.0 Hz, PhCH2), 4.00 (d, 1H, J¼11.0 Hz, PhCH2), 3.96 (br s,
1H, OH, D2O exchangeable), 3.93–3.89 (m, 1H, H-3), 3.81 (d, 1H,
J¼4.2 Hz, H-4), 3.45 (d, 1H, J¼10.6 Hz, H-5), 3.26 (dd, 1H, J¼4.2,
Major diastereomer: Rf 0.10 (EtOAc–PE¼1:3); colorless wax; [
a]
D
þ12.6 (c 2.29, CHCl3); IR (film): 3404, 3030, 2921, 1612, 1513, 1454,
1394, 1247, 1173, 1029 cmꢀ1; 1H NMR (400 MHz, CDCl3)
d
7.36–7.18
(m, 10H, Ph-H), 6.91–6.84 (m, 4H, Ph-H), 4.75 (d, J¼8.3 Hz, 1H,
ArCH), 4.50 (d, 1H, J¼12.0 Hz, PhCH2), 4.42 (d, 1H, J¼12.0 Hz,
PhCH2), 4.05 (d, 1H, J¼11.6 Hz, PhCH2), 4.00 (d, 1H, J¼11.6 Hz,
PhCH2), 3.98–3.95 (m,1H, J¼5.4 Hz, H-4), 3.79 (s, 3H, OCH3), 3.66 (d,
1H, J¼4.5 Hz, H-3), 3.46 (d, 1H, J¼11.5 Hz, H-5), 3.32 (dd, 1H, J¼4.5,
8.3 Hz, H-2), 3.24 (dd, 1H, J¼5.4, 11.5 Hz, H-5); 13C NMR (100 MHz,
10.6 Hz, H-5); 13C NMR (100 MHz, CDCl3)
d 146.4, 145.0, 137.6,
137.4, 128.5 (2C), 128.4 (2C), 128.1 (2C), 128.0 (2C), 127.9 (2C), 127.9,
127.9 (2C), 127.8, 126.8, 126.6, 126.2 (2C), 126.1 (2C), 83.4, 81.0, 77.9,
72.1, 70.8, 60.9; MS (ESI, m/z): 482 (MþHþ, 100), 504 (MþNaþ, 81).
Anal. Calcd for C31H31NO4: C, 77.31; H, 6.49; N, 2.91. Found: C,
77.12; H, 6.47; N, 2.89.
CDCl3)
d 159.3, 137.6, 137.4, 133.3, 128.5 (2C), 128.3 (2C), 128.2 (2C),
127.8 (2C), 127.6 (2C), 127.6, 113.8 (2C), 113.6, 80.7, 79.0, 77.7, 75.2,
71.5, 71.3, 61.2, 55.2; MS (ESI, m/z): 436 (MþHþ, 100), 458 (MþNaþ,
18); HRMS (ESI) calcd for [C26H29NO5þH]þ: 436.2124; found:
436.2127.
4.3.2. (2R,3S,4S)-3,4-Bis(benzyloxy)-2-(1-hydroxy-1-phenylethyl)-
N-hydroxypyrrolidine (9b). Following the general procedure, the
SmI2-mediated
a
-hydroxyalkylations of 8 (100 mg, 0.336 mmol)
4.3.5. (2S,3S,4S)-2-{(Benzo[d][1,3]dioxol-5-yl)hydroxymethyl}-3,4-
with acetophenone (0.12 mL, 1.01 mmol) gave compound 9b as
a mixture of two diastereomers in 84:16 ratio (determined by 1H
NMR, dH 3.32, 3.13) (eluent:EtOAc–PE¼1:4; 68 mg, combined yield:
50%). A part of the major diastereomer was isolated in pure form
bis(benzyloxy)-N-hydroxypyrrolidine (9e). Following the general
procedure, the SmI2-mediated a-hydroxyalkylations of 8 (100 mg,
0.34 mmol) with piperonal (151 mg, 1.01 mmol) gave compound 9e
as a mixture of two diastereomers in 83:17 ratio (determined by 1H
NMR, dH 3.26, 3.15) (eluent:EtOAc–PE¼1:3; 139 mg, combined
yield: 92%). A part of the major diastereomer was isolated in pure
from column chromatographic separation. Major diastereomer: Rf
20
0.39 (EtOAc–PE¼1:3); colorless wax; [
a]
þ2.7 (c 0.48, CHCl3); IR
D
(film): 3342, 3030, 2922, 2851, 1600, 1495, 1453, 1207, 1096,
form from column chromatographic separation. Major di-
20
1028 cmꢀ1 1H NMR (400 MHz, CDCl3)
;
d
7.52–7.48 (m, 2H, Ph-H),
astereomer: Rf 0.15 (EtOAc–PE¼1:3); colorless wax; [
a
]
þ7.5 (c
D
7.39–7.28 (m, 12H, Ph-H), 7.24–7.20 (m, 1H, Ph-H), 4.58 (d, 1H,
J¼11.8 Hz, PhCH2), 4.52 (2d, overlapped, 2H, J¼11.8 Hz, J¼11.4 Hz,
PhCH2), 4.48 (d, 1H, J¼11.4 Hz, PhCH2), 4.18 (d, 1H, J¼3.7 Hz, H-3),
3.90 (d, 1H, J¼4.7 Hz, H-4), 3.42 (d, 1H, J¼3.7 Hz, H-2), 3.41 (d, 1H,
J¼10.8 Hz, H-5), 3.13 (dd, 1H, J¼4.7, 10.8 Hz, H-5), 1.54 (s, 3H, CH3);
0.47, CHCl3); IR (film): 3373, 3030, 2922, 1605, 1503, 1488, 1443,
1246, 1095, 1039 cmꢀ1 1H NMR (400 MHz, CDCl3)
;
d
7.37–7.22 (m,
8H, Ph-H), 6.99–6.93 (m, 2H, Ph-H), 6.92–6.88 (m, 1H, Ph-H), 6.83–
6.78 (m, 1H, Ph-H), 6.74–6.70 (m, 1H, Ph-H), 5.92–5.87 (m, 2H,
OCH2O), 4.72 (d, 1H, J¼8.3 Hz, ArCH), 4.51 (d, 1H, J¼12.0 Hz, PhCH2),
4.42 (d, 1H, J¼12.0 Hz, PhCH2), 4.11 (d, 1H, J¼11.6 Hz, PhCH2), 4.02
(d, 1H, J¼11.6 Hz, PhCH2), 3.96 (d, 1H, J¼5.2 Hz, H-4), 3.66 (d, 1H,
J¼4.5 Hz, H-3), 3.47 (d, 1H, J¼11.5 Hz, H-5), 3.28 (dd, 1H, J¼4.5,
8.3 Hz, H-2), 3.23 (dd, 1H, J¼5.2, 11.5 Hz, H-5); 13C NMR (100 MHz,
13C NMR (100 MHz, CDCl3)
d 147.0, 137.6, 137.5, 128.5 (2C), 128.5
(2C), 128.2 (2C), 128.0 (2C), 127.9 (2C), 127.9 (2C), 127.8, 126.7, 125.4,
82.9, 82.1, 78.2, 73.7, 71.7, 71.0, 60.8, 26.8; MS (ESI, m/z): 420
(MþHþ, 100), 442 (MþNaþ, 77). Anal. Calcd for C26H29NO4: C,
74.44; H, 6.97; N, 3.34. Found: C, 74.51; H, 7.30; N, 3.01.
CDCl3) d 147.8, 147.2, 137.5, 137.4, 135.2, 128.7, 128.5 (2C), 128.2 (2C),
127.8 (2C), 127.6, 127.5 (2C), 120.5, 108.0, 107.6, 100.9, 84.0, 80.6,
78.8, 75.5, 71.5, 71.3, 61.3; MS (ESI, m/z): 472 (MþNaþ, 100), 450
(MþHþ, 34). Anal. Calcd for C26H27NO6: C, 69.47; H, 6.05; N, 3.12.
Found: C, 69.80; H, 6.03; N, 2.94.
4.3.3. (2S,3S,4S)-3,4-Bis(benzyloxy)-2-[(4-chlorophenyl)hydrox-
ymethyl]-N-hydroxypyrrolidine (9c). Following the general pro-
cedure, the SmI2-mediated
a-hydroxyalkylations of 8 (100 mg,
0.34 mmol) with 4-chlorobenzaldehyde (142 mg, 1.01 mmol) gave
compound 9c as a mixture of two diastereomers in 85:15 ratio
(determined by 1H NMR, dH 3.29, 3.16) (eluent:EtOAc–PE¼1:4;
111 mg, combined yield: 75%). A part of the major diastereomer was
4.3.6. (3S,4S)-3,4-Bis(benzyloxy)-2-(1-hydroxybutyl)-N-hydrox-
ypyrrolidine (9f). Following the general procedure, the SmI2-me-
diated
a-hydroxyalkylations of 8 (100 mg, 0.336 mmol) with
isolated in pure form from column chromatographic separation.
butyraldehyde (0.127 mL, 1.44 mmol) gave compound 9f as a mix-
ture of four inseparable diastereomers in 43:27:17:13 ratio (de-
termined by HPLC) (eluent:EtOAc–PE¼1:3; 112 mg, combined
yield: 90%). Rf 0.20 (EtOAc–PE¼1:3); colorless wax; IR (film): 3341,
3030, 2957, 2925, 2870, 1587, 1496, 1454, 1360, 1094, 1028 cmꢀ1; 1H
20
Major diastereomer: Rf 0.31 (EtOAc–PE¼1:2); colorless wax; [
a]
D
þ4.2 (c 1.19, CHCl3); IR (film): 3432, 3033, 2898, 1596, 1490, 1454,
1410, 1145, 1088, 1028, 1014 cmꢀ1 1H NMR (400 MHz, CDCl3)
7.42–7.22 (m, 12H, Ph-H), 6.97–6.90 (m, 2H, Ph-H), 4.77 (d, 1H,
;
d
J¼7.3 Hz, ArCH), 4.52 (d, 1H, J¼11.9 Hz, PhCH2), 4.44 (d, 1H,
NMR (400 MHz, CDCl3)
4H, PhCH2), 4.05–4.00, 4.00–3.96 (2 m, 1H, CH2CHOH), 3.95–3.90,
d 7.40–7.22 (m, 10H, Ph-H), 4.64–4.39 (m,
J¼11.9 Hz, PhCH2), 4.18 (d, 1H, J¼11.5 Hz, PhCH2), 4.09 (d, 1H,